ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA

Clinical trials for ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear

Sign up with your email to follow new studies for ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Early trial tests new combo for Tough-to-Treat blood cancer

Disease control Terminated

This early-stage study aims to find the safest and most effective dose of the drug lenalidomide when given alongside a standard chemotherapy regimen (called EPOCH) for adult T-cell leukemia/lymphoma (ATLL), a rare and aggressive cancer. It will involve about 30 adults with ATLL t…

Matched conditions: ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA

Get alerted when new ACUTE ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear

Early trial tests new combo for Tough-to-Treat blood cancer